Second-trimester maternal serum marker screening: Maternal serum α-fetoprotein, β-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome

作者: Yuval Yaron , Michele Cherry , Ralph L. Kramer , Joseph E. O’Brien , Mordechai Hallak

DOI: 10.1016/S0002-9378(99)70334-0

关键词: EstriolHuman chorionic gonadotropinGynecologyIntrauterine growth restrictionOligohydramniosPregnancyMiscarriageObstetricsPrenatal diagnosisMedicineGonadotropinObstetrics and gynaecology

摘要: Objective: We evaluated the value of all 3 common biochemical serum markers, maternal α-fetoprotein, β-human chorionic gonadotropin, and unconjugated estriol, combinations thereof as predictors pregnancy outcome. Study Design: A total 60,040 patients underwent screening. All had α-fetoprotein measurements; gonadotropin was measured in 45,565 patients, 24,504 determination including estriol. The incidences various outcomes were according to marker levels by using clinically applied cutoff points. Results: In confirmation previous observations, increased (>2.5 multiples median) found be significantly associated with pregnancy-induced hypertension, miscarriage, preterm delivery, intrauterine growth restriction, fetal death, oligohydramnios, abruptio placentae. Increased median [MoM]) death. Finally, decreased estriol (<0.5 MoM) As second-trimester levels, low are adverse outcomes. These most likely attributed placental dysfunction. Conclusion: Multiple-marker screening can used not only for detection anomalies aneu-ploidy but also high-risk pregnancies. (Am J Obstet Gynecol 1999;181:968-74.)

参考文章(26)
Laurence I. Burd, Joanna Jessup, Joaquin Santolaya-Forgas, Gail S. Prins, Barbara K. Burton, Pregnancy outcome in women with low midtrimester maternal serum unconjugated estriol. Journal of Reproductive Medicine. ,vol. 41, pp. 87- 90 ,(1996)
Edward A. Perkes, Roger S. Baim, Kenneth J. Goodman, James N. Macri, Second-trimester placental changes associated with elevated maternal serum α-fetoprotein American Journal of Obstetrics and Gynecology. ,vol. 144, pp. 935- 938 ,(1982) , 10.1016/0002-9378(82)90188-0
Carolyn M. Salafia, Lester Silberman, Nilo E. Herrera, Maurice J. Mahoney, Placental pathology at term associated with elevated midtrimester maternal serum α-fetoprotein concentration American Journal of Obstetrics and Gynecology. ,vol. 158, pp. 1064- 1066 ,(1988) , 10.1016/0002-9378(88)90220-7
D.J.H. Brock, Lilias Barron, Paddy Jelen, Muriel Watt, J.B. Scrimgeour, MATERNAL SERUM-ALPHA-FETOPROTEIN MEASUREMENTS AS AN EARLY INDICATOR OF LOW BIRTH-WEIGHT The Lancet. ,vol. 310, pp. 267- 268 ,(1977) , 10.1016/S0140-6736(77)90952-7
James N. Macri, Prenatal Diagnosis of Neural Tube Defects JAMA: The Journal of the American Medical Association. ,vol. 236, pp. 1251- 1254 ,(1976) , 10.1001/JAMA.1976.03270120027019
Susanna N. Dyer, Barbara K. Burton, Lewis H. Nelson, Elevated maternal serum α-fetoprotein levels and oligohydramnios: Poor prognosis for pregnancy outcome American Journal of Obstetrics and Gynecology. ,vol. 157, pp. 336- 339 ,(1987) , 10.1016/S0002-9378(87)80164-3
Aubrey Milunsky, Linda Nebiolo, Maternal Serum Triple Analyte Screening and Adverse Pregnancy Outcome Fetal Diagnosis and Therapy. ,vol. 11, pp. 249- 253 ,(1996) , 10.1159/000264310
N. J. WALD, H. S. CUCKLE, J. W. DENSEM, K. NANCHAHAL, J. A. CANICK, J. E. HADDOW, G. J. KNIGHT, G. E. PALOMAKI, Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome British Journal of Obstetrics and Gynaecology. ,vol. 95, pp. 334- 341 ,(1988) , 10.1111/J.1471-0528.1988.TB06602.X
Lewis H. Nelson, Jeanette Bensen, Barbara K. Burton, Outcomes in patients with unusually high maternal serum α-fetoprotein levels American Journal of Obstetrics and Gynecology. ,vol. 157, pp. 572- 576 ,(1987) , 10.1016/S0002-9378(87)80009-1